Status:
ACTIVE_NOT_RECRUITING
Evaluation of the Implementation of Drug Prescription Recommendations Using Clinical Decision Support in Patients With Severe Obesity: Retrospective Study
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Rennes University Hospital
Conditions:
Obesity, Morbid
Drug Use
Eligibility:
All Genders
18-65 years
Brief Summary
No drug prescription guidelines for severe obesity (BMI\>35 kg/m2) are available, leading to non-standardized and / or potentially inappropriate drug management. After validation of guidelines by the...
Detailed Description
No drug prescription guidelines for severe obesity (BMI\>35 kg/m2) are available, leading to non-standardized and / or potentially inappropriate drug management. After validation of guidelines by the...
Eligibility Criteria
Inclusion
- All patients aged 18 to 65 at the time of prescription with a BMI\>35 kg/m² present in the clinical data warehouse of the HEGP and CHU Rennes during the study period with at least one hospitalization of more than 24h.
Exclusion
- Patients who refused to have their records processed electronically.
- Patients with a history of bariatric surgery (sleeve gastrectomy, gastric band, gastric bypass) prior to hospitalization.
Key Trial Info
Start Date :
June 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 9 2026
Estimated Enrollment :
1050 Patients enrolled
Trial Details
Trial ID
NCT06517303
Start Date
June 9 2023
End Date
June 9 2026
Last Update
July 26 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
HEGP
Paris, France, 75015
2
CHU de Rennes
Rennes, France, 35000